FDA Approves Abiomed’s Impella ECP Heart Pump
Abiomed announced that the U.S. FDA has approved the version of Impella ECP heart pump that will be used in the Impella ECP Pivotal Trial.
Abiomed announced that the U.S. FDA has approved the version of Impella ECP heart pump that will be used in the Impella ECP Pivotal Trial.
Abiomed announced that the U.S. FDA has approved the version of Impella ECP heart pump that will be used in the Impella ECP Pivotal Trial.